Quality of life in psoriasis and its relationship to clinical severity- An Original Research
DOI:
https://doi.org/10.61841/qrch8t53Keywords:
Erythema, Psoriasis, ScalingAbstract
Psoriasis affects approximately 2% of the world's population, affecting both men and women. The present study was conducted to assess the effects of psoriasis severity PASI on the patient’s quality of life PDI.The present study was conducted on 100 cases of Psoriasis of both genders. An assessment of psoriasis was made using the psoriasis area and severity index (PASI). The PASI score was calculated by subjective assessment of 3 factors: erythema (E), induration (I), and scaling (S). The majority of the patients (22%) were in the age group of 61-70 years. There was female preponderance (58%) while male patients constituted 42% of the study group. The M:F ratio was 1:1.4. 38% participants were regular tobacco users while 22% and 12% participants smoked and drank alcohol respectively. 52% patients had psoriasis for 0-5 years followed by 27% patients that had psoriasis for 6-10 years, 6% for 11-15 years, 8% for 16-20 years, 5% for 21-25 years and 2% for >25 years. The severity of psoriasis was graded according to the PASI score. 40% patients had mild psoriasis (PASI<7), 26% of patients had psoriasis of moderate severity (PASI 7 -12) while 3 4% had severe type (PASI>12). The mean PASI score was 9.17±4.67. The quality of Life (QoL) was most affected in daily activities (90%), followed by work (85%), leisure (72%), problems with treatment (68%) and the least affected was in personal relations (65%). Severity of psoriasis as per PASI has no correlation with psoriasis related Quality of Life (QoL) as per PDI in our study. The quality of Life (QoL) was most affected in daily activities and it was also observed that all aspects of (QoL) was affected more by patients having psoriasis of less severity on sensitive sites of head/neck and hand/foot as compared to patients having psoriasis of more severity on other parts of the body.
Downloads
References
1. Finlay AY, Kelly SE. Psoriasis - An index of disability. Clin Exp Dermatol 1987;12:8-11.
2. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effects of psoriasis on health related quality of life. J Am Acad Dermatol 2002;4:512-8.
3. Hrehorów E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta Derm Venereol 2012;92:67-72.
4. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35.
5. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
6. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63
7. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995; 34: 700-703.
8. Kumar S, Akhtar T, Islam WA, Chopra D and Kaur R. Quality of life evaluation in women Psoriatic patients. Int. J. of Life Sciences 2017; 5(1): 93-96.
9. Perrott SB, Murray AH, Lowe J, Ruggiero KM (2000) The personal-group discrimination discrepancy in persons living with psoriasis. Basic Appl Social Psychol;22: 57–67.
10. Misery L, Thomas L, Jullien D, Cambazard F, Humbert P, Dubertret L, Dehen L, Macy G, Boussetta S, Taieb C (2008)Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol; 18: 412–415.
11. Manjula VD, Sreekiran S, Saril PS, Sreekanth MP. A study of psoriasis and quality of life in a tertiary care teaching hospital of Kottayam, Kerala. Indian J Dermatol 2011;56:403-6
12. Finlay AY, Khan GK, Luscombe DK, Salek MS (1990) Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol;123:751-756.
13. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE (1998) Quality of life measures in psoriasis: A critical appraisal of their quality. J Clin Pharm Ther;23:391-8.
14. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ (2004) Determinants of quality of life in patients with psoriasis: A study from the US population. J Am Acad Dermatol; 51:704-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
